Bookmark and Share
BioAssay: AID 651610

HIV entry: Env-mediated Cell Fusion Measured in Cell-Based System Using Plate Reader - 7013-01_Inhibitor_SinglePoint_HTS_Activity

Although some inhibitors of HIV-1 entry exist, these are not suitable for use in a prophylactic setting because of limitations in potency, breadth and/or adaptability to a microbicide formulation. HIV-1 Envs expressed on the surface of cells can mediate the fusion of cells with target cells expressing the CD4 and CCR5/CXCR4 receptors, such as CEM lymphoblasts. We have established an assay that more ..
_
   
 Tested Compounds
 Tested Compounds
All(354812)
 
 
Active(3866)
 
 
Inactive(348488)
 
 
Inconclusive(2510)
 
 
 Tested Substances
 Tested Substances
All(356894)
 
 
Active(3871)
 
 
Inactive(350512)
 
 
Inconclusive(2511)
 
 
 Related BioAssays
 Related BioAssays
AID: 651610
Data Source: Broad Institute (7013-01_Inhibitor_SinglePoint_HTS_Activity)
BioAssay Type: Primary, Primary Screening, Single Concentration Activity Observed
Depositor Category: NIH Molecular Libraries Probe Production Network
BioAssay Version:
Deposit Date: 2012-10-02
Modify Date: 2012-10-24

Data Table ( Complete ):           View Active Data    View All Data
BioActive Compounds: 3866
Related Experiments
Show more
AIDNameTypeComment
651609Broad Institute MLPCN HIV Entry Inhibitor Probe ProjectSummarydepositor-specified cross reference: Summary
652040Control Cell Fusion Counterscreen Assay Measured in Cell-Based System Using Plate Reader - 7013-02_Inhibitor_Dose_CherryPick_ActivityConfirmatorysame project related to Summary assay
652042CEM21 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7013-03_Inhibitor_Dose_CherryPick_ActivityConfirmatorysame project related to Summary assay
652057HIV entry: Env-mediated Cell Fusion Measured in Cell-Based System Using Plate Reader - 7013-01_Inhibitor_Dose_CherryPick_ActivityConfirmatorysame project related to Summary assay
652058Cell fusion assay for clade C HIV-1ZM109 Env Measured in Cell-Based System Using Plate Reader - 7013-05_Inhibitor_Dose_CherryPick_ActivityConfirmatorysame project related to Summary assay
652062HIV-1 Cell Fusion assay for clade B Env AD8 Measured in Cell-Based System Using Plate Reader - 7013-04_Inhibitor_Dose_CherryPick_ActivityConfirmatorysame project related to Summary assay
687021Control Cell Fusion Counterscreen Assay Measured in Cell-Based System Using Plate Reader - 7013-02_Inhibitor_Dose_DryPowder_ActivityConfirmatorysame project related to Summary assay
687023HIV entry: Env-mediated Cell Fusion Measured in Cell-Based System Using Plate Reader - 7013-01_Inhibitor_Dose_DryPowder_ActivityConfirmatorysame project related to Summary assay
687026CEM21 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7013-03_Inhibitor_Dose_DryPowder_ActivityConfirmatorysame project related to Summary assay
Description:
Keywords: cell fusion, Env protein, HIV, luciferase

Assay Overview:

Although some inhibitors of HIV-1 entry exist, these are not suitable for use in a prophylactic setting because of limitations in potency, breadth and/or adaptability to a microbicide formulation. HIV-1 Envs expressed on the surface of cells can mediate the fusion of cells with target cells expressing the CD4 and CCR5/CXCR4 receptors, such as CEM lymphoblasts. We have established an assay that monitors the cell-cell fusion activity of HIV-1 Envs with a firefly luciferase readout. In our primary high-throughput screen (HTS), a modified HeLa cell line that inducibly expresses the Envs of a primary HIV-1 strain (HIV-1JRFL) will be co-cultivated with receptor-bearing target cells (CEM21) in the presence of the compounds to be screened. CEM21 expresses a Tet-activator responsive Luciferase reporter. This is a Tetracycline regulated system and when the Tet-activator from the Env-expressing cell line is transferred into the target cell upon successful fusion, the Luciferase reporter will be activated. Detection of Luciferase will occur using the SteadyGlo reagent (Promega, Madison, WI). Maraviroc, a known CCR5 antagonist, that blocks Env-mediated cell fusion will be used as a positive control.

Expected Outcome: Compounds that inhibit cell fusion will cause a decrease in Luciferase signal.
Protocol
HIV Fusion Assay Protocol (Streamlined version for HTS)
1.Grow JRFL effector cells in DMEM passage medium with Doxycycline. Split 1:3 or 1:4 for passing. For HTS: 4 days prior to plating, thaw 3 vials (1.0 x 10;7 cells/ vial) into 4 triple flasks with 120 mL DMEM passage medium/flask. After 3 days, transfer to 3 Hyperflasks (HF) with ~550 mL RPMI induction media (~33 million cells per HF)
2.Day 0: Pass JRFL cells to DoxFree. Wash cells 2x with PBS & add 15 ml Accutase per triple to detach cells. Stop Accutase by adding RPMI induction media. Spin down cells & seed 9-10 x10;6 cells in 120 ml of RPMI induction medium in triple flask.
3.Day 1: Plating of JRFL cells. Wash cells with PBS & add 15 ml Accutase for triple or 50 ml for HF to detach cells (@ 37 degrees C). Stop by adding RPMI induction medium. Spin down the cells at 1200 rpm for 5 min & re-suspend in phenol red-free RPMI induction medium (with Puromycin).
4.Count cells, adjust to 1.25 x10;5 cells/mL & seed 2,500 cells per well in 20 microl of RPMI (no Phenol Red) induction medium in Aurora white, opaque 384 well plates.
5.Day 2: Pinning & adding CEM21 cells Spin down & count CEM21 cells. Adjust to 5.0x10;5 cells/ml in RPMI fusion medium. Dispense 5,000 cells at 10 microl/well in RPMI induction media. Pin transfer compounds to the plate. Positive control is Maraviroc to a final concentration of ~300 nM. Incubate the plate 37 degrees C O/N.
6.Day 3: SteadyGlo & Read. Add 10 microl of room temperature Steady-Glo substrate. Wait 10 minutes & read luminescence with ultrasensitive settings on Perkin-Elmer EnVision with 0.5 second read time per well.
Media Recipes:
DMEM passage medium (1 L):
DMEM 882 mL
Heat Inactivated-FBS 100 mL
Pen-Strep-L-Glu 10 mL
*Doxycycline (1 mg/mL) 2 mL
Puromycin (10 mg/mL) 100 microL
Geniticin (50 mg/mL)4 mL
RPMI induction medium (DoxFree) (1 L):
RPMI (-Phenol red)890 mL
10 % Tet approved HI-FBS100 mL
Pen-Strep-L-Glu 10 mL
Puromycin (10 mg/mL)100 microL
Notes
.Doxycycline is light sensitive so minimize light exposure
.All cells have to be in exponential growth phase. JRFL & Hela-F-Luc cells are usually split 1:3 every 2-3 days, CEM 21 are split 1:10 every 3 days. Cells should not be allowed to overgrow in the flasks.
.CEM21 cells take 1-2 weeks after thawing to grow at an optimal rate
.Cells must be spun down after dissociation to remove StemPro Accutase from the medium.
.Cells can be allowed to fuse 16 to 24 hours.
-Effector (JRFL) cells should be propagated for no more than 30 passages or 3 months whichever is sooner.
Comment
PRESENCE OF CONTROLS: Neutral control wells (NC) and positive control wells (PC) were included on every plate.
EXPECTED OUTCOME: Active compounds result in decreasing readout signal.
NORMALIZATION:
The raw signals of the plate wells were normalized using the 'Neutral Controls Minus Inhibitors' method in Genedata Assay Analyzer (v7.0.3):
The median raw signal of the intraplate neutral control wells was set to a normalized activity value of 0.
The median raw signal of the intraplate positive control wells was set to a normalized activity value of -100.
Experimental wells values were scaled to this range.
All well activities were then multiplied by -1 to create a positive activity readout value range, to match Pubchem convention.
PATTERN CORRECTION: The plate pattern correction algorithm 'Runwise Pattern (Additive)' in Genedata (v7.0.3) was applied to the normalized plate data.
PUBCHEM_ACTIVITY_SCORE:
This was set as equal to the mean of the normalized and corrected sample replicate activities, rounded to the nearest integer .
The minimum PUBCHEM_ACTIVITY_SCORE required for a compound to be called a hit (the activity threshold, or AT) was set at 50.
PERCENTAGE OF ACTIVE REPLICATES:
For each sample, the percentage of replicates (PCT_ACTIVE_REP) which had activity scores >= AT was determined.
The minimum percentage of replicates required for a compound to be called a hit (PAR_T) was set at 100.
PUBCHEM_ACTIVITY_OUTCOME:
Samples passing BOTH threshold criteria were assigned an outcome of 2 (active):
PUBCHEM_ACTIVITY_SCORE >= AT, and PCT_ACTIVE_REP >= PAR_T
Samples passing NEITHER threshold criteria were assigned an outcome of 1 (inactive):
PUBCHEM_ACTIVITY_SCORE < AT, and PCT_ACTIVE_REP < PAR_T
Samples passing AT only were assigned an outcome of 3 (inconclusive) :
PUBCHEM_ACTIVITY_SCORE >= AT, and PCT_ACTIVE_REP < PAR_T
Samples passing PAR_T only were assigned an outcome of 3 (inconclusive) :
PUBCHEM_ACTIVITY_SCORE < AT, and PCT_ACTIVE_REP >= PAR_T
Categorized Comment - additional comments and annotations
From PubChem:
Assay Format: Cell-based
Assay Cell Type: HeLa
Result Definitions
TIDNameDescriptionHistogramTypeUnit
OutcomeThe BioAssay activity outcomeOutcome
ScoreThe BioAssay activity ranking scoreInteger
1REPRODUCIBILITY_COSINE_TRANSFORMA measure of how well the activity reproduced across the two samples. Computed as the absolute value of the cosine between the 'replicate vector' (ScoreA, ScoreB ---as well as ScoreC and/or ScoreD where applicable) and the vector (1, 1) representing perfect reproducibility. NULL will appear in this column if a sample was not run in duplicate or if the data produced by one of the replicates was Invalid# Float
2PCT_ACTIVE_REPLICATESThe percentage of replicates which pass the activity threshold.Float
3REPLICATE_A_ACTIVITY_SCORE_16.66uM_(%) (16.66μM**)Float%
4REPLICATE_B_ACTIVITY_SCORE_16.66uM_(%) (16.66μM**)Float%
5REPLICATE_A_ACTIVITY_SCORE_12.29uM_(%) (12.29μM**)The calculated activity for the indicated sampleFloat%
6REPLICATE_B_ACTIVITY_SCORE_12.29uM_(%) (12.29μM**)The calculated activity for the indicated sampleFloat%

** Test Concentration.
Additional Information
Grant Number: 1 R03 DA034601-01

Data Table (Concise)
Data Table ( Complete ):     View Active Data    View All Data
PageFrom: